Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.22.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Total revenue $ 20 $ 209
Operating expenses:    
Cost of goods sold 207 163
Selling, general and administrative 11,014 7,368
Research and development 5,259 2,636
Total operating expenses 16,480 10,167
Loss from operations (16,460) (9,958)
Other income (expense):    
Change in fair value of warrant liability   3
Other income, net 45 69
Interest income 24 48
Gain (loss) on foreign currency exchange 2 (4)
Total other income, net 71 116
Net loss and comprehensive loss $ (16,389) $ (9,842)
Per share information:    
Net loss per share of common stock, basic (in dollars per share) $ (0.10) $ (0.06)
Net loss per share of common stock, diluted (in dollars per share) $ (0.10) $ (0.06)
Weighted average common shares outstanding, basic (in shares) 165,520,007 160,508,373
Weighted average common shares outstanding, diluted (in shares) 165,520,007 160,508,373
Product revenue    
Revenue:    
Total revenue   $ 209
License revenue    
Revenue:    
Total revenue $ 20